Your browser doesn't support javascript.
loading
A multi-institution phase II study of docetaxel and S-1 in combination with trastuzumab for HER2-positive advanced gastric cancer (DASH study).
Kagawa, Shunsuke; Muraoka, Atsushi; Kambara, Takeshi; Nakayama, Hiroshi; Hamano, Ryosuke; Tanaka, Norimitsu; Noma, Kazuhiro; Tanakaya, Kohji; Kishimoto, Hiroyuki; Shigeyasu, Kunitoshi; Kuroda, Shinji; Kikuchi, Satoru; Kuwada, Kazuya; Nishizaki, Masahiko; Shirakawa, Yasuhiro; Fujiwara, Toshiyoshi.
Afiliación
  • Kagawa S; Department of Gastroenterological Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Science, 2-5-1 Shikata-cho, Kita-ku, Okayama, 700-8558, Japan. skagawa@md.okayama-u.ac.jp.
  • Muraoka A; Minimally Invasive Therapy Center, Okayama University Hospital, Okayama, Japan. skagawa@md.okayama-u.ac.jp.
  • Kambara T; Department of Surgery, Kagawa Rosai Hospital, Marugame, Japan.
  • Nakayama H; Department of Surgery, Chugoku Central Hospital, Fukuyama, Japan.
  • Hamano R; Department of Surgery, Himeji Central Hospital, Himeji, Japan.
  • Tanaka N; Department of Surgery, Fukuyama Medical Center, Fukuyama, Japan.
  • Noma K; Department of Surgery, Kagawa Prefectural Central Hospital, Takamatsu, Japan.
  • Tanakaya K; Department of Gastroenterological Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Science, 2-5-1 Shikata-cho, Kita-ku, Okayama, 700-8558, Japan.
  • Kishimoto H; Department of Surgery, Iwakuni Clinical Center, Iwakuni, Japan.
  • Shigeyasu K; Department of Gastroenterological Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Science, 2-5-1 Shikata-cho, Kita-ku, Okayama, 700-8558, Japan.
  • Kuroda S; Department of Gastroenterological Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Science, 2-5-1 Shikata-cho, Kita-ku, Okayama, 700-8558, Japan.
  • Kikuchi S; Department of Gastroenterological Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Science, 2-5-1 Shikata-cho, Kita-ku, Okayama, 700-8558, Japan.
  • Kuwada K; Department of Gastroenterological Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Science, 2-5-1 Shikata-cho, Kita-ku, Okayama, 700-8558, Japan.
  • Nishizaki M; Minimally Invasive Therapy Center, Okayama University Hospital, Okayama, Japan.
  • Shirakawa Y; Department of Gastroenterological Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Science, 2-5-1 Shikata-cho, Kita-ku, Okayama, 700-8558, Japan.
  • Fujiwara T; Department of Gastroenterological Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Science, 2-5-1 Shikata-cho, Kita-ku, Okayama, 700-8558, Japan.
Cancer Chemother Pharmacol ; 81(2): 387-392, 2018 02.
Article en En | MEDLINE | ID: mdl-29290024
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Gástricas / Protocolos de Quimioterapia Combinada Antineoplásica / Receptor ErbB-2 Tipo de estudio: Clinical_trials / Observational_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Año: 2018 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Gástricas / Protocolos de Quimioterapia Combinada Antineoplásica / Receptor ErbB-2 Tipo de estudio: Clinical_trials / Observational_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Año: 2018 Tipo del documento: Article